Hapvida offers to buy Intermédica

Hapvida offers to buy Intermédica

M&A Equity Capital Markets Brazil

Brazilian private healthcare company Hapvida has made a non-binding proposal to acquire rival Notre Dame Intermédica in an all-share deal, it said in a securities filing on Friday. Hapvida will own 53.1% of the combined company, while Intermédica will have 46.9%, accounting for a 10% premium on the average share prices for both companies over 20 days through December 21 last year, Hapvida said. According to press reports, the tie-up could create a company with a market capitalization up to BRL12

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial